Drug
Zolbetuximab
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Ascites | 106 | 58.6 | 63.8 | signal |
| 2 | Salivary Hypersecretion | 16 | 26.0 | 26.3 | signal |
| 3 | Myelosuppression | 54 | 25.8 | 26.9 | signal |
| 4 | Gastritis | 40 | 24.7 | 25.5 | signal |
| 5 | Neutrophil Count Decreased | 57 | 22.8 | 23.9 | signal |
| 6 | Ileus | 13 | 17.1 | 17.3 | signal |
| 7 | Malignant Neoplasm Progression | 102 | 16.3 | 17.6 | signal |
| 8 | Motor Dysfunction | 9 | 14.4 | 14.5 | signal |
| 9 | Feeding Disorder | 17 | 13.8 | 14.0 | signal |
| 10 | Oedema | 43 | 12.9 | 13.3 | signal |
| 11 | Cerebral Infarction | 19 | 12.6 | 12.8 | signal |
| 12 | Pneumonia Aspiration | 19 | 12.4 | 12.5 | signal |
| 13 | Decreased Appetite | 175 | 12.3 | 14.0 | signal |
| 14 | Palmar-plantar Erythrodysaesthesia Syndrome | 16 | 11.1 | 11.2 | signal |
| 15 | Nausea | 499 | 10.3 | 16.1 | signal |
| 16 | Retching | 13 | 9.9 | 10.0 | signal |
| 17 | Taste Disorder | 12 | 9.7 | 9.8 | signal |
| 18 | Hepatic Cytolysis | 7 | 9.3 | 9.3 | signal |
| 19 | Full Blood Count Decreased | 11 | 8.9 | 8.9 | signal |
| 20 | Hepatic Encephalopathy | 5 | 8.7 | 8.7 | signal |
| 21 | Interstitial Lung Disease | 24 | 8.1 | 8.2 | signal |
| 22 | Metastases To Bone | 8 | 7.9 | 8.0 | signal |
| 23 | Infusion Related Reaction | 28 | 6.9 | 7.0 | signal |
| 24 | Metastases To Central Nervous System | 5 | 6.3 | 6.4 | signal |
| 25 | Intercepted Product Preparation Error | 4 | 5.3 | 5.3 | signal |
| 26 | Gastric Cancer | 7 | 4.4 | 4.4 | signal |